Search details
1.
Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC).
Cancer
; 124(6): 1216-1224, 2018 03 15.
Article
in English
| MEDLINE | ID: mdl-29266182
2.
Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders.
Br J Haematol
; 180(1): 71-81, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29105742
3.
Development of a method to isolate circulating tumor cells using mesenchymal-based capture.
Methods
; 64(2): 129-36, 2013 Dec 01.
Article
in English
| MEDLINE | ID: mdl-23845299
4.
Construction of repeat-free fluorescence in situ hybridization probes.
Nucleic Acids Res
; 40(3): e20, 2012 Feb.
Article
in English
| MEDLINE | ID: mdl-22123742
5.
Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab.
Leukemia
; 35(2): 573-584, 2021 02.
Article
in English
| MEDLINE | ID: mdl-32457357
6.
Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide.
Prostate Cancer Prostatic Dis
; 24(2): 448-456, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33009489
7.
A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia.
Blood Adv
; 4(5): 906-919, 2020 03 10.
Article
in English
| MEDLINE | ID: mdl-32150609
8.
Development of a Novel c-MET-Based CTC Detection Platform.
Mol Cancer Res
; 14(6): 539-47, 2016 06.
Article
in English
| MEDLINE | ID: mdl-26951228
Results
1 -
8
de 8
1
Next >
>>